Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Open Surgery

Research Leaders

20 sponsors active, led by Karolinska University Hospital

Related Conditions

Often studied with 18 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 2 (1)
Phase 4 (1)

Trial Status

Completed2
Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07206355Recruiting

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT07262957Phase 4Recruiting

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

NCT02167711Phase 2CompletedPrimary

Treatment for Bile Duct Cancer in the Liver

NCT02081131Not ApplicableCompleted

Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)

Showing all 4 trials

Research Network

Common Treatments

  • Open Surgery1
  • Laparoscopic Surgery1
  • Sirt Yttrium901
  • Hop Bundle1

Active Sponsors

  • Karolinska University Hospital1
  • Lund University Hospital1
  • Catharina Ziekenhuis Eindhoven1
  • Chinese University of Hong Kong1
  • Sahlgrenska University Hospital1

Top Investigators

Related Conditions

  • Duodenal Carcinoma1
  • Pancreatic Cancer1
  • Ipmn Pancreatic1
  • Duodenal Adenocarcinoma1
  • Biliary Tract Cancer Btc1

Activity Timeline